Earnings
NBY
0.9132
+1.81%
0.0162
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
6.94M
--
--
1.07M
--
--
0.00
--
492.00K
--
781.00K
105.00K
9.38M
1.36M
--
--
--
--
--
--
477.00K
1.84M
11.22M
--
331.00K
2.61M
--
--
--
--
--
2.71M
--
--
--
37.00K
5.69M
0.00
--
--
--
4.56M
4.56M
10.25M
279.00K
125.72M
-125.02M
--
--
--
973.00K
973.00K
11.22M
FY 2018-12-31
3.18M
--
--
3.38M
--
--
0.00
--
280.00K
--
1.37M
387.00K
8.61M
201.00K
--
--
--
--
--
--
552.00K
753.00K
9.36M
--
551.00K
0.00
--
--
--
--
--
973.00K
--
--
--
2.32M
3.85M
0.00
--
--
--
560.00K
560.00K
4.41M
171.00K
119.76M
-114.98M
--
--
--
4.95M
4.95M
9.36M
FY 2017-12-31
3.20M
--
--
3.63M
--
--
0.00
--
504.00K
--
1.23M
433.00K
8.99M
471.00K
--
--
--
--
--
--
613.00K
1.08M
10.08M
--
466.00K
0.00
--
--
--
--
--
1.67M
--
--
--
2.84M
4.98M
0.00
--
--
--
2.51M
2.51M
7.49M
154.00K
113.51M
-111.07M
--
--
--
2.59M
2.59M
10.08M
FY 2016-12-31
9.51M
--
--
2.12M
--
--
0.00
--
873.00K
--
1.51M
459.00K
14.47M
371.00K
--
--
--
--
--
--
539.00K
910.00K
15.38M
--
455.00K
0.00
--
--
--
--
--
1.80M
--
--
--
2.07M
4.32M
0.00
--
--
--
3.96M
3.96M
8.28M
153.00K
110.62M
-103.67M
--
--
--
7.10M
7.10M
15.38M
FY 2015-12-31
2.38M
--
--
536.00K
--
--
0.00
--
1.34M
--
261.00K
--
4.53M
395.00K
--
--
--
--
--
--
155.00K
550.00K
5.08M
--
2.48M
0.00
--
--
--
--
--
1.98M
--
--
--
170.00K
4.63M
1.66M
--
--
--
3.89M
5.54M
10.18M
35.00K
85.39M
-90.52M
--
--
--
-5.10M
-5.10M
5.08M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out NBY latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze NOVABAY PHARMA recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.